http://www.ncbi.nlm.nih.gov/pubmed/22932170
"An uncontrolled open-label, multicenter study to monitor the antiviral activity and safety of inhaled zanamivir (as Rotadisk via Diskhaler device) among Chinese adolescents and adults with influenza-like illness."
Are GSK setting up for a post-patent push into China?